New Delhi, Oct 28 || The pharma and healthcare sector in India witnessed robust deal momentum valued at $3.5 billion in Q3 2025, according to a report on Tuesday.
Grant Thornton Bharat’s Pharma and Healthcare Dealtracker report showed that the sector recorded a total of 72 transactions, up 28 per cent in volumes and 166 per cent in value quarter on quarter.
This included three IPOs worth $ 428 million and one QIP worth $88 million, the report said.
Excluding public market activity, private deals accounted for $ 3 billion across 68 transactions, marking a sharp rebound in investor appetite.